|
|
Volumn 23, Issue 7, 2005, Pages 765-
|
|
Teva to acquire Chinese biogenerics manufacturer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GROWTH HORMONE;
BIOLOGICAL FACTOR;
DRUG APPROVAL;
DRUG COST;
DRUG MANUFACTURE;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
IMMUNOGENICITY;
IN VITRO STUDY;
NOTE;
PRIORITY JOURNAL;
ARTICLE;
BIOTECHNOLOGY;
CHINA;
DRUG INDUSTRY;
ECONOMICS;
ISRAEL;
LEGAL ASPECT;
BIOLOGICAL FACTORS;
BIOTECHNOLOGY;
CHINA;
DRUG INDUSTRY;
ISRAEL;
|
|
EID: 24944461069
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0705-765 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
